SAN MATEO

Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock

Retrieved on: 
星期二, 一月 23, 2024

SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the commencement of an underwritten public offering of 9,000,000 shares of its Series A common stock.

Key Points: 
  • SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the commencement of an underwritten public offering of 9,000,000 shares of its Series A common stock.
  • All of the shares in the proposed offering are to be sold by Sagimet.
  • In addition, Sagimet expects to grant the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of its Series A common stock in the offering.
  • Goldman Sachs & Co. LLC, TD Cowen and Leerink Partners are acting as joint book-running managers for the offering.

Backblaze Names David Ngo Chief Product Officer

Retrieved on: 
星期二, 一月 23, 2024

SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Backblaze, Inc. (Nasdaq: BLZE), the leading specialized storage cloud, today announced that David Ngo has joined the company as Chief Product Officer (CPO).

Key Points: 
  • SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Backblaze, Inc. (Nasdaq: BLZE), the leading specialized storage cloud, today announced that David Ngo has joined the company as Chief Product Officer (CPO).
  • Ngo previously served as the global chief technology officer (CTO) for Metallic, a division of Commvault, which provides data protection and cyber resilience as a service.
  • “I am pleased to welcome David as our new Chief Product Officer.
  • David brings impressive engineering, design and product leadership to Backblaze,” said Gleb Budman, Backblaze CEO and Chairperson of the Board.

Orion Governance Announces the Extension of Python Support to Snowflake’s Snowpark

Retrieved on: 
星期二, 一月 23, 2024

San Mateo, California, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Orion Governance Inc., the Information Intelligence Company and provider of Enterprise Information Intelligence Graph (EIIG), a self-defined data fabric, is delighted to announce the extension of Python support to Snowflake's Snowpark.

Key Points: 
  • San Mateo, California, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Orion Governance Inc., the Information Intelligence Company and provider of Enterprise Information Intelligence Graph (EIIG), a self-defined data fabric, is delighted to announce the extension of Python support to Snowflake's Snowpark.
  • Snowpark is utilized for deploying and processing non-SQL code to construct data pipelines, ML models, and applications within the Snowflake environment.
  • Orion's support for Python encompasses field-level lineage and embedded business logic within the Python code.
  • “At Orion Governance, we are proud to develop cutting-edge technology to empower organizations to drive value out of their data assets through automation, ” said Ramesh Shurma, CEO and Founder of Orion Governance.

Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

Retrieved on: 
星期一, 一月 22, 2024

SAN MATEO, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) --  Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced positive topline results from its FASCINATE-2 Phase 2b clinical trial of denifanstat versus placebo in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients with stage 2 or stage 3 fibrosis (F2/F3) at week 52. In this trial, denifanstat, an oral, selective FASN inhibitor, showed statistically significant improvements relative to placebo on both of the primary endpoints of NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS, and ≥2-point reduction in NAS without worsening of fibrosis. Denifanstat-treated patients also showed statistically significant fibrosis improvement by ≥ 1 stage with no worsening of NASH, and a greater proportion of MRI-derived proton density fat fraction (MRI-PDFF) ≥30% responders relative to placebo.

Key Points: 
  • “Denifanstat is designed to reduce the three main drivers of NASH, including fat accumulation, inflammation, and fibrosis, both independently and in parallel.
  • “Sagimet is committed to creating novel approaches to target dysfunctional metabolic pathways, and we believe these positive results represent a major advancement in that endeavor.
  • “Denifanstat is the only FASN inhibitor currently in clinical development for the treatment of NASH with related fibrosis.
  • Moreover, the safety profile supports the further development of denifanstat in NASH patients.”

BrightEdge Releases New Data, Shows Companies How Significantly Google’s New AI-Powered Search Engine Will Impact Their Business

Retrieved on: 
星期四, 一月 18, 2024

According to the data , an estimated 84% of queries on Google Search will be boosted by generative AI.

Key Points: 
  • According to the data , an estimated 84% of queries on Google Search will be boosted by generative AI.
  • The data also shows that healthcare, e-commerce and B2B technology industries will be impacted the most significantly.
  • Google is expected to imminently go live with SGE, which uses AI to supercharge Search.
  • As Google’s latest launch catapults us from query-driven search to conversation-driven, AI-enabled search, the data clearly shows that businesses need to prepare themselves for a Search revolution.”

Backblaze Launches Enterprise Control to Support Advanced Administration and Data Protection Needs

Retrieved on: 
星期三, 一月 17, 2024

Enterprise Control brings the value businesses love in Backblaze Computer Backup—including unlimited backups, one year version history, and simple, affordable pricing—and adds advanced administration tools that large businesses require both to protect workstations and meet ever-evolving cybersecurity requirements.

Key Points: 
  • Enterprise Control brings the value businesses love in Backblaze Computer Backup—including unlimited backups, one year version history, and simple, affordable pricing—and adds advanced administration tools that large businesses require both to protect workstations and meet ever-evolving cybersecurity requirements.
  • “We’re excited at the possibility of having even more control to meet our growing administration and data protection needs with this new Computer Backup with Enterprise Control solution.”
    Backblaze Computer Backup with Enterprise Controls features and benefits include:
    Fine-Grained Permissions: Allows administrators to control access to group member data on a granular level for enterprise operations.
  • “Backblaze Computer Backup with Enterprise Control builds on our history of providing unlimited data backup and ransomware protection for organizations large and small," said Gleb Budman, Backblaze CEO and Chairperson of the Board.
  • Backblaze shared more information about the Backblaze Computer Backup with Enterprise Control on their blog .

Introducing Incorta X: Unleashing AI and ML capabilities for transformative business insights

Retrieved on: 
星期二, 一月 16, 2024

Incorta X enables finance and operational teams to access their critical data faster than any other solution, creating a huge competitive advantage for their companies.

Key Points: 
  • Incorta X enables finance and operational teams to access their critical data faster than any other solution, creating a huge competitive advantage for their companies.
  • With Incorta X, business users can now perform complex data engineering tasks, removing administrative burdens and enabling them to become strategic employees that deliver valuable insights.
  • The Global Semantic Layer: Maintain a full inventory of analytics assets with a metadata-enriched analytics catalog to support ML and generative AI use cases.
  • To learn more about Incorta X and its transformative capabilities, visit incorta.com/Incortax

Freshworks to Participate in 26th Annual Needham Growth Conference

Retrieved on: 
星期四, 一月 11, 2024

SAN MATEO, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Freshworks Inc. , (NASDAQ: FRSH) today announced that Tyler Sloat, Chief Financial Officer, is scheduled to participate in a fireside chat at the 26th Annual Needham Growth Conference on Wednesday, January 17, 2024 at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time.

Key Points: 
  • SAN MATEO, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Freshworks Inc. , (NASDAQ: FRSH) today announced that Tyler Sloat, Chief Financial Officer, is scheduled to participate in a fireside chat at the 26th Annual Needham Growth Conference on Wednesday, January 17, 2024 at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time.

SIOS Reveals Technology Predictions for 2024

Retrieved on: 
星期三, 一月 10, 2024

SAN MATEO, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- SIOS Technology Corp ., an industry leader in application high availability (HA) and disaster recovery (DR), today announced top technology predictions for 2024.

Key Points: 
  • SAN MATEO, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- SIOS Technology Corp ., an industry leader in application high availability (HA) and disaster recovery (DR), today announced top technology predictions for 2024.
  • These hurdles are expected to extend into 2024, thereby heightening the demand for robust IT solutions that prioritize high availability (HA) and disaster recovery (DR).
  • Cassius Rhue, VP of Customer Experience, SIOS Technology, predicts the following major trends driven by these expectations:
    Application high availability becomes universal.
  • “As reliance on applications continues to rise, IT teams will be pressured to deliver efficient high availability for applications once considered non-essential.

Freshworks to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024

Retrieved on: 
星期二, 一月 9, 2024

SAN MATEO, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the fourth quarter and full year ended December 31, 2023 following the close of market on Tuesday, February 6, 2024.

Key Points: 
  • SAN MATEO, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the fourth quarter and full year ended December 31, 2023 following the close of market on Tuesday, February 6, 2024.
  • Freshworks will host a live audio webcast beginning at 2:00 p.m Pacific Time / 5:00 p.m. Eastern Time that same day to discuss the company’s financial results and business highlights.
  • A webcast replay will be accessible from the Freshworks investor relations website at https://ir.freshworks.com .
  • The press release will be accessible from the Freshworks investor relations website prior to the commencement of the event.